The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often viewed as outdated and hindering progress, https://asiyaymup288573.wikiannouncement.com/9587165/cannabinoid_rescheduling_a_expansion_catalyst